Jindal, T., Jiang, C. Y., Alhalabi, O., Nguyen, C. B., Oh, E., Tsung, I., … Koshkin, V. S. (2026). Outcomes with Enfortumab Vedotin in Patients with Histologic Subtypes of Advanced Urothelial Carcinoma: Analysis of the UNITE Study. Eur Urol, 90(1), 85–87. https://doi.org/10.1016/j.eururo.2025.09.003

Jindal, Tanya, Cindy Y. Jiang, Omar Alhalabi, Charles B. Nguyen, Eugene Oh, Irene Tsung, Dimitra Rafailia Bakaloudi, et al. “Outcomes with Enfortumab Vedotin in Patients with Histologic Subtypes of Advanced Urothelial Carcinoma: Analysis of the UNITE Study.” Eur Urol 90, no. 1 (July 2026): 85–87. https://doi.org/10.1016/j.eururo.2025.09.003.

Jindal T, Jiang CY, Alhalabi O, Nguyen CB, Oh E, Tsung I, et al. Outcomes with Enfortumab Vedotin in Patients with Histologic Subtypes of Advanced Urothelial Carcinoma: Analysis of the UNITE Study. Eur Urol. 2026 Jul;90(1):85–7.

Jindal, Tanya, et al. “Outcomes with Enfortumab Vedotin in Patients with Histologic Subtypes of Advanced Urothelial Carcinoma: Analysis of the UNITE Study.” Eur Urol, vol. 90, no. 1, July 2026, pp. 85–87. Pubmed, doi:10.1016/j.eururo.2025.09.003.

Jindal T, Jiang CY, Alhalabi O, Nguyen CB, Oh E, Tsung I, Bakaloudi DR, Talukder R, Davidsohn M, Freeman D, Epstein IY, Ding C-KC, Nizam A, Glover MJ, Khaki AR, Taylor AK, Lemke E, Jang A, Evans ST, Shin D, Pywell C, Basu A, Bilen MA, Zakharia Y, Barata P, Milowsky MI, Brown J, Kilari D, Emamekhoo H, Hoimes CJ, Shah S, Davis NB, Gupta S, Grivas P, Bellmunt J, Alva A, Campbell MT, Koshkin VS. Outcomes with Enfortumab Vedotin in Patients with Histologic Subtypes of Advanced Urothelial Carcinoma: Analysis of the UNITE Study. Eur Urol. 2026 Jul;90(1):85–87.